Conference 2022

ATiO Conference 2022

Latest ATiO Conference Impressions

This Year’s Keynote Speakers

Conference Agenda & Schedule

Location And Host City

Conference Sponsors

Next ATiO Conference

Latest ATiO Conference Impressions

"The ATiO gathering has finally brought together the right stakeholders to bring innovation from the bench to the bedside. We need more initiatives like this and I can’t wait to contribute to the next efforts of this vibrant and diverse community of professionals in the regenerative medicine theatre."

- Prof. Dr. Lorenzo Moroni, FYAE, Director, MERLN 

 

"This inaugural ATiO meeting was a sensational start for a new organization aimed at pushing the frontier of biologics in a highly collaborative intimate setting of leaders in our field. I look forward to acting on some of the many important ideas presented."

- Scott Bruder, CEO & Founder, Bruder Consulting & Venture Group

 

"The first ATiO Conference 2022 bought stakeholders from different backgrounds, such as academia, industry and finance, together. Running a World Cafe Session, focusing on Innovation and Entrepreneurship was a great experience to widen my knowledge in the field of regenerative medicine."

- Jan Engels, Investment Manager, HTGF

 

“I thoroughly enjoyed the 2022 ATiO conference and the many excellent (translational) presentations by leaders and decision-makers in the field.”

- Joost de Bruijn, PhD, CEO, Kuros

Keynote Speakers

 

 
 
 
 
 

Scott P. Bruder, MD, PhD

  • Founder and CEO, Bruder Consulting Venture Group, LLC

  • Adjunct Professor, Biomedical Engineering and Orthopaedic Surgery, Case Western Reserve University

  • Co-Editor, “Orthobiologics: Scientific and Clinical Solutions for Orthopaedic Surgeons” (AAOS, in press)

Dr. Bruder is the Founder and CEO of the Bruder Consulting & Venture Group, providing product development, regulatory, compliance, reimbursement and commercialization support for companies engaged in tissue repair and regeneration.  He is the former Chief Medical and Scientific Officer of Stryker Corporation, and Member of FDA’s Advisory Panel on Human Cell, Tissue and Gene Therapy. Prior to that he was the CSO at Becton, Dickinson & Co, and spent almost a decade at J&J building a portfolio of regenerative therapeutic products across multiple disciplines. 

Over the last 25 years he has launched dozens of products, earning billions of dollars for his employers and patent licensors, published over 125 papers, abstracts and chapters, and received the highest scientific awards from the AAOS, ORS, ABJS and AIMBE. His landmark patents on the use of MSCs for treating orthopaedic conditions moved the entire platform from autologous to allogeneic cell therapy in a variety of companies around the world. Dr. Bruder maintains his academic ties as an Adjunct Professor at Case Western Reserve University, where he earned his MD and his PhD in the lab of Prof. Arnold Caplan.

Dr. Fabian Klein

  • Head @Ashurst's German IP Team

  • Legal Advisor to national & international clients in all areas of intellectual property and copyright law

  • Member @Ashurst's Healthcare Practice Group

Dr. Klein's practice focuses on trademark law, unfair competition law and the protection of trade secrets. He has extensive experience in the strategic protection of IP rights, the enforcement in contentious and non-contentious proceedings, as well as advising and negotiating complex IP contracts such as licence agreements, research and development agreements (including in publicly funded projects) and co-operation agreements. He regularly advises on the IP aspects in M&A transactions as well as on medical-related advertising claims.

 

Dr. Christian A. Stein

  • CEO @ Ascenion GmbH

  • Chairman @TransferAllianz

  • Chairman @MGC Foundation

  • Member @International Strategy Committee, American Association of University Technology Managers (AUTM)

Before becoming CEO of Ascenion in 2001, Christian Stein headed the project management department at the Fraunhofer Patent Centre for German Research. From 2014 to 2016 he was President of ASTP, the European Association of Knowledge and Technology Transfer Professionals and Board Member of the global Association of Technology Transfer Professionals (ATTP) from 2012 until 2015.

Christian has founded several companies in and outside the biotechnology field. He is a consultant and advisor to various EU programs as well as regional and national expert groups, serves as a member of the Supervisory Board of ISAR Bioscience in Munich and is on the advisory board of a number of biotechnology companies.

Christian holds a PhD in molecular biology and obtained a Master of Science (MSc) in Management of Intellectual Property Law from QMW in London.

 

Prof. Dr. Dietmar W. Hutmacher

  • Chair in Regenerative Medicine @Queensland University of Technology (QUT)

  • Director Max Planck Queensland Center (MPQC) for the Materials Science of Extracellular Matrices @Queensland University of Technology, Australia

Professor Hutmacher’s fundamental and applied research made a transformative impact in TE&RM and leaped to the forefront of biomaterials science. His research on 3D printing in combination with the development of novel biomaterials has yielded not only new insights into tissue engineering mechanisms and new technologies to control them, but has also provided a new paradigm for research conducted at the interface of engineering and medicine and specifically regenerative medicine. His comprehensive studies published in > 300 publications on biodegradable scaffolds and additive biomanufacturing provided quantitative analysis to describe the scaffold design requirements in respect to mechanical properties, degradation rate, morphology and surface engineering. Hence, he pioneered the field of scaffold-guided tissue regeneration (SGTR). These studies have fueled groundbreaking fundamental as well as translational advances in the field of SGTR as evidenced by his citation metrics Scaffold design - #2 Worldwide and #1 Asia-Pacific; Additive biomanufacturing - #1 Worldwide (SciVal metrics). His eminent academic career, former industry experience, and MBA have equipped him with the scientific expertise, leadership profile, and management experience to undertake cutting edge basic and translational research which has led to significant improvements in our fundamental understandings, yet from a far wider-reaching health care perspective his work and innovations have improved the quality of life for many patients.

Dr. rer. nat. Katharina Schmidt-Bleek

  • Research Group Leader “Biology of Bone Healing” @Julius-Wolff-Institute

  • Principal Investigator “Osteoimmunology” @Julius-Wolff-Institute

The research interest of Dr. rer. nat. Katharina Schmidt-Bleek lies in the decoding of the regenerative capacity of bone tissue. This research area allows her to combine her two majors, molecular biology and veterinary medicine, to study the bone organ both in vitro and in vivo. Of particular interest is the interaction of the immune system, with a focus on the adaptive immune system, and the bone system.

The complex processes of bone healing, adaptation and homeostasis offer numerous fascinating research approaches that address unsolved clinical problems. In particular, the demographic aging of our population generates new research priorities. The still young field of osteoimmunology offers new, promising therapeutic approaches. Basic research for the development of such therapeutic approaches is the focus of Katharina Schmidt-Bleek's research group.

 

 

 

 

 

Conference Agenda & Schedule

Location And Host City

The ATiO Conference 2022 will be hosted in Berlin @Hotel de Rome, Behrenstraße 37, 10117 Berlin

 

Hotel de Rome
Hotel de Rome

Hotel de Rome

Hotel de Rome
Hotel de Rome

Hotel de Rome

Hotel de Rome
Hotel de Rome

Hotel de Rome

Hotel de Rome
Hotel de Rome

Hotel de Rome

Hotel de Rome
Hotel de Rome

Hotel de Rome

Early Stage Corporate Presentation Contest

Congratulations to mimiX Biotherapeutics Ltd represented by CEO Marc Thurner for winning the 1st Early Stage Corporate Presentation Contest!

 

Conference Sponsors

Next ATiO Conference

The next ATiO Conference will be held from

18. - 20.05.23

in Berlin, Germany.